接种COVID-19疫苗和糖尿病酸性脂肪酸症
1Academic Center, Sanitation1 Medical Academic Center, Bangkok 1033300, Thailand. beuyjoob@hotmail.com.
World journal of diabetes
|June 5, 2023
概括
COVID-19疫苗很少会导致内分泌问题,包括新发糖尿病和糖尿病酸性糖尿病. 建议在接种疫苗后对易受伤害的个体进行仔细监测,例如1型糖尿病患者.
科学领域:
- 内分泌学 在内分泌学.
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,需要有效的疫苗接种策略.
- 疫苗接种后的副作用正在受到审查,特别是与内分泌有关的问题.
- 糖尿病及其并发症是全球重要的健康问题.
研究的目的:
- 为了调查COVID-19疫苗接种后潜在的内分泌并发症.
- 为了突出报告的糖尿病发病和疫苗接种后恶化病例.
- 为了向临床实践提供有关糖尿病疫苗接种者的信息.
主要方法:
- 关于COVID-19疫苗副作用的临床报告和文献的审查.
- 分析与内分泌相关的不良事件,特别是糖尿病.
- 案例研究示例,包括超大胞性高血糖症状态和糖尿病酸性脂肪酸症.
主要成果:
- 在COVID-19疫苗接种后报告的新发型2型糖尿病 (超大分子高血糖状态) 的罕见病例.
- 在COVID-19疫苗和糖尿病酸性糖尿病之间可能存在关联.
- 观察到的常见症状:口渴,多滴水症,多尿症,心跳,食欲丧失,疲劳.
结论:
- 接种COVID-19疫苗可能与罕见的内分泌并发症有关,包括糖尿病.
- 高血糖和酸性是潜在的,虽然不常见的,疫苗接种后事件.
- 易受伤害的群体,如1型糖尿病患者,需要在接种疫苗后提高临床注意力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Insulin: Dosing Regimen and Adverse Effects
216
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
216


